These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 24935237)

  • 1. Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations.
    Brigo F; Erro R; Marangi A; Bhatia K; Tinazzi M
    Parkinsonism Relat Disord; 2014 Aug; 20(8):808-14. PubMed ID: 24935237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
    Ba F; Martin WR
    Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
    Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
    Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.
    Morley JF; Duda JE
    J Parkinsons Dis; 2014; 4(2):169-73. PubMed ID: 24284418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinsonism: alternative diagnosis beyond idiopathic Parkinson's disease].
    Gutiérrez J; Singer C
    Rev Med Inst Mex Seguro Soc; 2010; 48(3):279-92. PubMed ID: 21192900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating Parkinson's disease from other parkinsonian disorders.
    Alvarez MV; Evidente VG; Driver-Dunckley ED
    Semin Neurol; 2007 Sep; 27(4):356-62. PubMed ID: 17701873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of parkinsonism and Parkinson's disease.
    Camicioli R
    Drugs Today (Barc); 2002 Oct; 38(10):677-86. PubMed ID: 12582453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial sonography in the discrimination of Parkinson's disease versus vascular parkinsonism.
    Venegas-Francke P
    Int Rev Neurobiol; 2010; 90():147-56. PubMed ID: 20692499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.
    Brigo F; Matinella A; Erro R; Tinazzi M
    Eur J Neurol; 2014 Nov; 21(11):1369-e90. PubMed ID: 24779862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease.
    Katzenschlager R; Zijlmans J; Evans A; Watt H; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1749-52. PubMed ID: 15548497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on diffusion MRI in Parkinson's disease and atypical parkinsonism.
    Meijer FJ; Bloem BR; Mahlknecht P; Seppi K; Goraj B
    J Neurol Sci; 2013 Sep; 332(1-2):21-9. PubMed ID: 23866820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinsonism or Parkinson's disease unmasked by pentoxifylline?].
    Serrano-Dueñas M
    Neurologia; 2001 Jan; 16(1):39-42. PubMed ID: 11234661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medio-lateral balance impairment differentiates between Parkinson's disease and atypical parkinsonism.
    Nonnekes J; Aerts MB; Abdo WF; Bloem BR
    J Parkinsons Dis; 2014; 4(4):567-9. PubMed ID: 25125484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial sonography findings in welding-related Parkinsonism in comparison to Parkinson's disease.
    Walter U; Dressler D; Lindemann C; Slachevsky A; Miranda M
    Mov Disord; 2008 Jan; 23(1):141-5. PubMed ID: 17987651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of Parkinson's disease.
    Tolosa E; Wenning G; Poewe W
    Lancet Neurol; 2006 Jan; 5(1):75-86. PubMed ID: 16361025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data.
    Swarztrauber K; Anau J; Peters D
    Mov Disord; 2005 Aug; 20(8):964-70. PubMed ID: 15834854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
    Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
    Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.